nach oben

Erschienen in:

18.03.2019 | consensus statement

Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition

Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology

verfasst von: Vesna Bjelic-Radisic, MD, Christian Singer, Karl Tamussino, Heinz Kölbl, Edgar Petru, Birgit Volgger, Stephan Polterauer, Peter Oppelt, Paul Sevelda, Gerhard Bogner, Christian Marth, Austrian Gynecologic Oncology Working Group

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2019

Einloggen, um Zugang zu erhalten

Summary

The working group recommends against contralateral prophylactic mastectomy (CPM) in women with breast cancer without a family history or genetic predisposition with unilateral breast cancer. This is based on the low risk of developing contralateral breast cancer, the lack of a survival benefit, the increased risk of surgical complications, and the lack of benefit on quality of life.

Vorheriger Artikel Acupuncture is effective in improving functional communication in post-stroke aphasia

Nächster Artikel MUW researcher of the month

Bilateral breast cancer counts for two cases of breast cancer.

This recommendation is also pertinent to patients with cancer of the fallopian tube and primary peritoneal cancer.

Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol. 2016;23:3100–5.CrossRef

Pesce CE, Liederbach E, Czechura T, et al. Changig surgical trends in young patients with early stage breast cancer, 2003–2010: A report from the National Cancer Data base. J Am Coll Surg. 2014;219:19–30.CrossRef

Singer CF, Tea MK, Pristauz G, et al. Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families. Wien Klin Wochenschr. 2015;127:981–6.CrossRef

Schmutzler RK. Consensus recommendation of the German consortium on familial breast and ovarian cancer to deal with the results of the multigene analysis. Geburtshilfe Frauenheilkd. 2017;77(07):733–9. https://doi.org/10.1055/s-0043-108531.CrossRef

NCCN. NCCN guidelines; version 2.2019; Genetik/Familian high risk assessment: Breast and ovarian. 2018. https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=1476..

DGGG, DKG. Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Stuttgart: Thieme; 2018. Guideline of the DGGG and the DKG (S3-Level), AWMF Registry Number 032/045OL, December 2017.

Arbeitsgemeinschaft Gynäkologische Onkologie. Startseite. 2019. http://www.ago-online.de/de/start/..

Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evvaluation of the contralatral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.CrossRef

Andersopn K, Jacobson JS, Heitjan DF, et al. Cost-effectiveness of preventive strategies for women with a BRCA 1 or a BRCA2 mutation. Ann Intern Med. 2006;144:397–406.CrossRef

10.

Early Breast Cancer Trialists’Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randmosed trials. Lancet. 2005;365:1687–1617.CrossRef

11.

Reiner AS, John EM, Brooks JD, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA 1 and BRCA 2 utations with a family history of breast cancer: A report from the Women’s Enviromental Caner and Radiation Epidemiology Study. J Clin Oncol. 2013;31:433–9.CrossRef

12.

Early Breast Cancer Trialists’Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factord to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–84.CrossRef

13.

Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breastcancer. Cochrane Database Syst Rev. 2018; https://doi.org/10.1002/14651858.cd002748.pub4.CrossRefPubMedPubMedCentral

14.

Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102(6):401–9.CrossRef

15.

Jatoi I, Parsons HM. Contralateral prophylactic mastectomy and its association with reduced mortality: Evidence for selection bias. Breast Cancer Res Treat. 2014;148(2):389–96. https://doi.org/10.1007/s10549-014-3160-y.CrossRefPubMedPubMedCentral

16.

Zeichner SB, Zeichner SB, Ruiz AL, et al. Improvedlong-term survivalwith contralateral prophylactic mastectomy among young women. Asian Pac J Cancer Prev. 2014;15(3):1155–62.CrossRef

17.

Zion SM, Slezak JM, Sellers TA, et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer. 2003;98:2152–60.CrossRef

18.

Miller ME, Czechura T, Martz B, et al. Operative risks associated with contralateral prophylactic mastectomy: A single institution experience. Ann Surg Oncol. 2013;20:4113–20.CrossRef

19.

Silva AK, Lapin B, Yao KA, et al. The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: A NSQIP analysis. Ann Surg Oncol. 2015;22:3474–80.CrossRef

20.

Osman F, Saleh F, Jackson TD, et al. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: An analysis of the NSQIP database. Ann Surg Oncol. 2013;20:3212–7.CrossRef

21.

Sharpe SM, Liederbach E, Czechura T, et al. Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003–2010: A report from the National Cancer Data Base. Ann Surg Oncol. 2014;21:2920–7.CrossRef

22.

Koslow S, Pharmer LA, Scott AM, et al. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol. 2013;20:3422–9.CrossRef

23.

Hwang ES, Locklear TD, Rushing CN, et al. Patient-reported outcomes after choice for contralateral prophylactic mastectomy. J Clin Oncol. 2016;34(13):1518–27.CrossRef

24.

Mitchell A, Ferguson D, Gill J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: A systematic review and meta-analysis. Lancet Oncol. 2013;34:721–32.CrossRef

25.

Schmitz K, Speck R, Sheree A, et al. Prevalence of breast cancer treatment sequelae over 6 years of follow up, the pulling through study. Cancer. 2012;118(8):2217–25.CrossRef

26.

Parker PA, Peterson SK, Shen Y, et al. Prospective study of psychosocial outcomes of having Contralateral prophylactic mastectomy among women with nonhereditary breast cancer. J Clin Oncol. 2018;36:2630–8. https://doi.org/10.1200/jco.2018.78.6442.CrossRefPubMed

27.

Rosenberg SM, Tracy MS, Meyer ME, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer cross-sectional survey. Ann Intern Med. 2013;159(6):373–81. https://doi.org/10.7326/0003-4819-159-6-201309170-00003.CrossRefPubMedPubMedCentral

28.

Frost MH, Scjhaid DJ, Sellers TA, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284:319–24.CrossRef

Titel: Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition
Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology
verfasst von: Vesna Bjelic-Radisic, MD
Christian Singer
Karl Tamussino
Heinz Kölbl
Edgar Petru
Birgit Volgger
Stephan Polterauer
Peter Oppelt
Paul Sevelda
Gerhard Bogner
Christian Marth
Austrian Gynecologic Oncology Working Group
Publikationsdatum: 18.03.2019
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 9-10/2019
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-019-1468-7

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9-10/2019

Alprostadil treatment of critical limb ischemia in hemodialysis patients

Sexual dimorphism in the anatomy of the ulnar collateral thumb ligament

MUW researcher of the month

Acupuncture is effective in improving functional communication in post-stroke aphasia

Veranstaltungstipps:

Cancer incidence in an Austrian alpine valley 1983–2012